SERPINE1 and head and neck neoplasm: We used RNA seq level 3 data of 520 head and neck tumor samples and 44 normal tissue samples included in The Cancer Genome Atlas Database (TCGA) (http://cancergenome.nih.gov/) to study changes in uPA, uPAR and SERPINE1 expression after malignant transformation and its capacity to predict patient survival.